[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:adenovirus-antibody":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Adenovirus Antibody",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05101213","Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients",[11],"Phase 1","RECRUITING","2026-08-03T03:52:12.406209Z","2026-05-05T02:43:28.347086Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04230356","Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant",[19],"Phase 2","2026-08-26T02:16:41.943926Z","2026-05-05T02:43:28.418059Z"]